Transthyretin-mediated Amyloid Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Transthyretin-mediated Amyloid Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) [Phase 3]
An extension study to evaluate the long-term safety of eplontersen in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM); i…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: The CARDIO-TTRansform Scintigraphy Sub-study
An update on the CARDIO-TTRansform scintigraphy sub-study for transthyretin-mediated amyloid cardiomyopathy; the study is currently active b…